skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Lee, Nancy Y ; Ferris, Robert L ; Psyrri, Amanda ; Haddad, Robert I ; Tahara, Makoto ; Bourhis, Jean ; Harrington, Kevin ; Chang, Peter Mu-Hsin ; Lin, Jin-Ching ; Razaq, Mohammad Abdul ; Teixeira, Maria Margarida ; Lövey, József ; Chamois, Jerome ; Rueda, Antonio ; Hu, Chaosu ; Dunn, Lara A ; Dvorkin, Mikhail Vladimirovich ; De Beukelaer, Steven ; Pavlov, Dmitri ; Thurm, Holger ; Cohen, Ezra

The lancet oncology, 2021-04, Vol.22 (4), p.450-462 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Migden, Michael R ; Rischin, Danny ; Schmults, Chrysalyne D ; Guminski, Alexander ; Hauschild, Axel ; Lewis, Karl D ; Chung, Christine H ; Hernandez-Aya, Leonel ; Lim, Annette M ; Chang, Anne Lynn S ; Rabinowits, Guilherme ; Thai, Alesha A ; Dunn, Lara A ; Hughes, Brett G.M ; Khushalani, Nikhil I ; Modi, Badri ; Schadendorf, Dirk ; Gao, Bo ; Seebach, Frank ; Li, Siyu ; Li, Jingjin ; Mathias, Melissa ; Booth, Jocelyn ; Mohan, Kosalai ; Stankevich, Elizabeth ; Babiker, Hani M ; Brana, Irene ; Gil-Martin, Marta ; Homsi, Jade ; Johnson, Melissa L ; Moreno, Victor ; Niu, Jiaxin ; Owonikoko, Taofeek K ; Papadopoulos, Kyriakos P ; Yancopoulos, George D ; Lowy, Israel ; Fury, Matthew G

The New England journal of medicine, 2018-07, Vol.379 (4), p.341-351 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Topalian, Suzanne L ; Bhatia, Shailender ; Amin, Asim ; Kudchadkar, Ragini R ; Sharfman, William H ; Lebbé, Celeste ; Delord, Jean-Pierre ; Dunn, Lara A ; Shinohara, Michi M ; Kulikauskas, Rima ; Chung, Christine H ; Martens, Uwe M ; Ferris, Robert L ; Stein, Julie E ; Engle, Elizabeth L ; Devriese, Lot A ; Lao, Christopher D ; Gu, Junchen ; Li, Bin ; Chen, Tian ; Barrows, Adam ; Horvath, Andrea ; Taube, Janis M ; Nghiem, Paul

Journal of clinical oncology, 2020-08, Vol.38 (22), p.2476-2487 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

Dunn, Lara A ; Sherman, Eric J ; Baxi, Shrujal S ; Tchekmedyian, Vatche ; Grewal, Ravinder K ; Larson, Steven M ; Pentlow, Keith S ; Haque, Sofia ; Tuttle, R Michael ; Sabra, Mona M ; Fish, Stephanie ; Boucai, Laura ; Walters, Jamie ; Ghossein, Ronald A ; Seshan, Venkatraman E ; Ni, Ai ; Li, Duan ; Knauf, Jeffrey A ; Pfister, David G ; Fagin, James A ; Ho, Alan L

The journal of clinical endocrinology and metabolism, 2019-05, Vol.104 (5), p.1417-1428 [Periódico revisado por pares]

Washington, DC: Endocrine Society

Texto completo disponível

Citações Citado por
5
Oncology for the rhinologist
Oncology for the rhinologist
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oncology for the rhinologist

Tam, Kenric ; Dunn, Lara A ; Cohen, Marc A

Current opinion in otolaryngology & head and neck surgery, 2024-02, Vol.32 (1), p.14-19

United States

Texto completo disponível

Citações Citado por
6
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

Rischin, Danny ; Migden, Michael R ; Lim, Annette M ; Schmults, Chrysalyne D ; Khushalani, Nikhil I ; Hughes, Brett G M ; Schadendorf, Dirk ; Dunn, Lara A ; Hernandez-Aya, Leonel ; Chang, Anne Lynn S ; Modi, Badri ; Hauschild, Axel ; Ulrich, Claas ; Eigentler, Thomas ; Stein, Brian ; Pavlick, Anna C ; Geiger, Jessica L ; Gutzmer, Ralf ; Alam, Murad ; Okoye, Emmanuel ; Mathias, Melissa ; Jankovic, Vladimir ; Stankevich, Elizabeth ; Booth, Jocelyn ; Li, Siyu ; Lowy, Israel ; Fury, Matthew G ; Guminski, Alexander

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000775 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
7
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma

Dunn, Lara A. ; Riaz, Nadeem ; Fury, Matthew G. ; McBride, Sean M. ; Michel, Loren ; Lee, Nancy Y. ; Sherman, Eric J. ; Baxi, Shrujal S. ; Haque, Sofia S. ; Katabi, Nora ; Wong, Richard J. ; Xiao, Han ; Ho, Alan L. ; Pfister, David G.

International journal of radiation oncology, biology, physics, 2020-03, Vol.106 (3), p.564-570 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma
Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma

Baxi, Shrujal S., MD ; Dunn, Lara A., MD ; Burtness, Barbara A., MD

Oral oncology, 2016-11, Vol.62, p.147-148 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer

Sherman, Eric J. ; Dunn, Lara A. ; Ho, Alan L. ; Baxi, Shrujal S. ; Ghossein, Ronald A. ; Fury, Matthew G. ; Haque, Sofia ; Sima, Cami S. ; Cullen, Grace ; Fagin, James A. ; Pfister, David G.

Cancer, 2017-11, Vol.123 (21), p.4114-4121 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies

Fan, Ming ; Kang, Jung Julie ; Lee, Anna ; Fan, Dan ; Wang, Huili ; Kitpanit, Sarin ; Fox, Pamela ; Sine, Kevin ; Mah, Dennis ; McBride, Sean M. ; Tsai, Chiaojung Jillian ; Riaz, Nadeem ; Dunn, Lara A. ; Sherman, Eric J. ; Michel, Loren ; Singh, Bhuvanesh ; Ganly, Ian ; Wong, Richard J. ; Boyle, Jay O. ; Cohen, Marc A. ; Lee, Nancy Y.

Cancer, 2020-01, Vol.126 (9), p.1905-1916 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (96)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (101)
  2. Conjunto de Dados  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2008  (3)
  2. 2008Até2014  (7)
  3. 2015Até2017  (18)
  4. 2018Até2021  (46)
  5. Após 2021  (29)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.